Profound Medical Corp. (PROF)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Technology	16.10M	10.68M	7.20M	6.68M	6.87M
Medical Technology Growth	50.73%	48.35%	7.75%	-2.79%	-5.90%
Total	16.10M	10.68M	7.20M	6.68M	6.87M
Total Growth	50.73%	48.35%	7.75%	-2.79%	-5.90%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Germany	773.00K	891.00K	1.84M	1.80M	2.71M
Germany Growth	-13.24%	-51.65%	2.62%	-33.63%	230.40%
Canada	3.08M	2.44M	230.00K	1.49M	2.08M
Canada Growth	26.28%	960.43%	-84.56%	-28.26%	-67.97%
United States of America (USA)	12.25M	7.35M	5.13M	3.40M	2.09M
United States of America (USA) Growth	66.60%	43.39%	50.99%	62.44%	-
Total	16.10M	10.68M	7.20M	6.68M	6.87M
Total Growth	50.73%	48.35%	7.75%	-2.79%	-5.90%

Data Source: S&P Global Market Intelligence Last updated: Mar 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error